LukeDavidZurbriggenMD
Hematology • Madison, WIHematologic Oncology
Clinical Assistant Professor of Medicine
Dr. Zurbriggen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UW Highland Ave
# 600
Madison, WI 53792Phone+1 608-263-5660
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2018 - 2021- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2015 - 2018
University of Wisconsin School of Medicine & Public HealthClass of 2015
Certifications & Licensure
WI State Medical License 2017 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsDoppler ultrasound screening in patients with newly diagnosed heparin-induced thrombocytopenia.Elyse I. Harris, Luke D. Zurbriggen, Matthew J. Brunner, Eliot C. Williams
Blood Advances. 2021-11-23 - 4 citationsPredictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K Moyo
Journal of Hematology & Oncology. 2022-07-16 - 14 citationsThe Multidisciplinary Management of Colorectal Cancer: Present and Future Paradigms.Chelsie K. Sievers, Jeremy D. Kratz, Luke D. Zurbriggen, Noelle K. LoConte, Sam J. Lubner
Clinics in Colon and Rectal Surgery. 2016-09-01
Journal Articles
- Unmasking the Master of Disguise: Defining Advancements in Diagnosis of Intravascular Large B-cell LymphomaMatthew Brunner, Luke D. Zurbriggen, Julie E. Chang, Journal of Clinical Haematology, 12/21/2020
- Hereditary Hematologic Malignancy Syndromes in Adults: From AYA to AARPLuke D. Zurbriggen, Kelcy Smith, Jane Churpek, Blood, 8/29/2020
Abstracts/Posters
- Comparative Outcomes of Relapsed Follicular Lymphoma Patients Treated with Novel Agents: A Multi-Center AnalysisLuke Zurbriggen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Lesion-Level Response Prediction From 18F-FDG PET/CT in Metastatic Melanoma Patients Treated with Immune Checkpoint BlockadeDaniel Huff, Luke D. Zurbriggen, Rena Shah, Mark Albertini, American Association of Physicists in Medicine, 7/14/2019
- Outcomes in Acute Lymphoblastic Leukemia at the University of Wisconsin: An Institutional Review.Luke D. Zurbriggen, Michael Fallon, Ryan J. Mattison, American Society of Hematology Annual Meeting, 12/7/2017
Committees
- Panel member, NCCN Histiocytic Neoplasm Panel 2022 - Present
Professional Memberships
- Member
- Member
- Histiocyte SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
